Ligand · 460
460 · 2-[5-(6-methylpyridin-2-yl)-2,3-dihydro-1H-pyrazol-4-yl]-1,5-naphthyridine
460, 2-[5-(6-methylpyridin-2-yl)-2,3-dihydro-1H-pyrazol-4-yl]-1,5-naphthyridine (C17 H15 N5, 289.3 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the…
- Component
- 460
- Formula
- C17 H15 N5
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
460 in 2 structures; the first of them:
- 1VJY · Crystal Structure of a Naphthyridine Inhibitor of Human TGF-beta Type I Receptor · 460 A999 · binds ILE211, VAL219, ALA230, VAL231, LYS232, GLU245, TYR249, LEU260 and 11 more
- 1VJY · Crystal structure of a naphthyridine inhibitor of human TGF- beta type I receptor · 460 A999 · binds ILE211, VAL219, ALA230, VAL231, LYS232, GLU245, TYR249, LEU260 and 11 more
Residues it binds most
LEU 2, VAL 2, ALA 2, ASP 2, TYR 2, GLU 2, GLY 2, HIS 2, ILE 2, LYS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.